{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:19:18Z","timestamp":1791951558515,"version":"4.3.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ferroptosis has emerged as a potential therapeutic target in cancer. This study shows the critical role of AGR2 in ferroptosis suppression across pancreatic cancer cell lines and in vivo models. Notably, human pancreatic cancer cells exhibit dose-dependent AGR2 upregulation upon exposure to ferroptosis inducers. Genetic ablation of AGR2 significantly sensitizes cells to ferroptosis through a p53-mediated mechanism, while p53 knockdown effectively rescues ferroptosis resistance. Mechanistic investigations demonstrate that AGR2 deficiency activates p53 signaling, downregulating the iron exporter SLC40A1 (encoding ferroportin\/FPN1), inducing intracellular iron overload and consequent ferroptosis. Clinically, we find a positive correlation between AGR2 and FPN1 expression in PDAC specimens, with co-elevation of both markers predicting unfavorable patient prognosis. Therapeutically, administration of an AGR2-targeting peptide synergizes with ferroptosis inducers, significantly enhancing cell death in PDAC models. Our findings not only elucidate a novel AGR2\/p53\/FPN1 regulatory axis in ferroptosis control but also propose innovative combination strategies for pancreatic cancer treatment.<\/jats:p>","DOI":"10.1038\/s41419-025-08263-y","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T17:16:47Z","timestamp":1764609407000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["AGR2 suppresses ferroptosis via the p53\/FPN1 regulatory axis and drives therapeutic vulnerabilities in pancreatic cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Ziying","family":"Jian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangqi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanzhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jizhou","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naipeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3639-9055","authenticated-orcid":false,"given":"Yuhong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4299-5379","authenticated-orcid":false,"given":"Zhiheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"8263_CR1","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1053\/j.gastro.2024.05.028","volume":"167","author":"CS Leonhardt","year":"2024","unstructured":"Leonhardt CS, Gustorff C, Klaiber U, Le Blanc S, Stamm TA, Verbeke CS, et al. Prognostic Factors for Early Recurrence After Resection of Pancreatic Cancer: A Systematic Review and Meta-Analysis. Gastroenterology. 2024;167:977\u201392.","journal-title":"Gastroenterology"},{"key":"8263_CR2","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1053\/j.gastro.2021.07.030","volume":"161","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Li H, Deng Y, Schuck K, Raulefs S, Maeritz N, et al. AGR2-Dependent Nuclear Import of RNA Polymerase II Constitutes a Specific Target of Pancreatic Ductal Adenocarcinoma in the Context of Wild-Type p53. Gastroenterology. 2021;161:1601\u201314.e1623.","journal-title":"Gastroenterology"},{"key":"8263_CR3","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1136\/gutjnl-2021-325137","volume":"71","author":"S Tian","year":"2022","unstructured":"Tian S, Chu Y, Hu J, Ding X, Liu Z, Fu D, et al. Tumour-associated neutrophils secrete AGR2 to promote colorectal cancer metastasis via its receptor CD98hc-xCT. Gut. 2022;71:2489\u2013501.","journal-title":"Gut"},{"key":"8263_CR4","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.canlet.2021.06.025","volume":"518","author":"H Zhang","year":"2021","unstructured":"Zhang H, Chi J, Hu J, Ji T, Luo Z, Zhou C, et al. Intracellular AGR2 transduces PGE2 stimuli to promote epithelial-mesenchymal transition and metastasis of colorectal cancer. Cancer Lett. 2021;518:180\u201395.","journal-title":"Cancer Lett"},{"key":"8263_CR5","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1038\/onc.2016.459","volume":"36","author":"L Dumartin","year":"2017","unstructured":"Dumartin L, Alrawashdeh W, Trabulo SM, Radon TP, Steiger K, Feakins RM, et al. ER stress protein AGR2 precedes and is involved in the regulation of pancreatic cancer initiation. Oncogene. 2017;36:3094\u2013103.","journal-title":"Oncogene"},{"key":"8263_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02814-5","volume":"22","author":"D Hussein","year":"2022","unstructured":"Hussein D, Alsereihi R, Salwati AAA, Algehani R, Alhowity A, Al-Hejin AM, et al. The anterior gradient homologue 2 (AGR2) co-localises with the glucose-regulated protein 78 (GRP78) in cancer stem cells, and is critical for the survival and drug resistance of recurrent glioblastoma: in situ and in vitro analyses. Cancer cell Int. 2022;22:387.","journal-title":"Cancer cell Int"},{"key":"8263_CR7","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s11658-024-00601-w","volume":"29","author":"SH Yuan","year":"2024","unstructured":"Yuan SH, Wu CC, Wang YC, Chan XY, Chu HW, Yang Y, et al. AGR2-mediated unconventional secretion of 14-3-3\u03b5 and \u03b1-actinin-4, responsive to ER stress and autophagy, drives chemotaxis in canine mammary tumor cells. Cellular Mol Biol Lett. 2024;29:84.","journal-title":"Cellular Mol Biol Lett"},{"key":"8263_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101927","volume":"6","author":"H Li","year":"2025","unstructured":"Li H, Zhang Z, Shi Z, Zhou S, Nie S, Yu Y, et al. Disrupting AGR2\/IGF1 paracrine and reciprocal signaling for pancreatic cancer therapy. Cell Rep. Med. 2025;6:101927.","journal-title":"Cell Rep. Med"},{"key":"8263_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.101928","volume":"6","author":"X Shen","year":"2025","unstructured":"Shen X, Chen Y, Tang Y, Lu P, Liu M, Mao T, et al. Targeting pancreatic cancer glutamine dependency confers vulnerability to GPX4-dependent ferroptosis. Cell Rep. Med. 2025;6:101928.","journal-title":"Cell Rep. Med"},{"key":"8263_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52978-z","volume":"15","author":"V de Laat","year":"2024","unstructured":"de Laat V, Topal H, Spotbeen X, Talebi A, Dehairs J, Idkowiak J, et al. Intrinsic temperature increase drives lipid metabolism towards ferroptosis evasion and chemotherapy resistance in pancreatic cancer. Nature Commun. 2024;15:8540.","journal-title":"Nature Commun"},{"key":"8263_CR11","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1182\/blood.2023023417","volume":"145","author":"O Marques","year":"2025","unstructured":"Marques O, Horvat NK, Zechner L, Colucci S, Sparla R, Zimmermann S, et al. Inflammation-driven NF-\u03baB signaling represses ferroportin transcription in macrophages via HDAC1 and HDAC3. Blood. 2025;145:866\u201380.","journal-title":"Blood"},{"key":"8263_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102435","volume":"56","author":"L Li","year":"2022","unstructured":"Li L, Wang K, Jia R, Xie J, Ma L, Hao Z, et al. Ferroportin-dependent ferroptosis induced by ellagic acid retards liver fibrosis by impairing the SNARE complexes formation. Redox Biol. 2022;56:102435.","journal-title":"Redox Biol"},{"key":"8263_CR13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/cai2.7","volume":"1","author":"C Zhang","year":"2022","unstructured":"Zhang C, Yu JJ, Yang C, Shang S, Lv XX, Cui B, et al. Crosstalk between ferroptosis and stress-Implications in cancer therapeutic responses. Cancer Innov. 2022;1:92\u2013113.","journal-title":"Cancer Innov"},{"key":"8263_CR14","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.ccell.2024.04.009","volume":"42","author":"Y Liu","year":"2024","unstructured":"Liu Y, Su Z, Tavana O, Gu W. Understanding the complexity of p53 in a new era of tumor suppression. Cancer cell. 2024;42:946\u201367.","journal-title":"Cancer cell"},{"key":"8263_CR15","doi-asserted-by":"crossref","unstructured":"Zhao S, Liu X, Luo R, Jian Z, Xu C, Hou Y, et al. USP38 functions as an oncoprotein by downregulating the p53 pathway through deubiquitination and stabilization of MDM2. Cell Death Differ. 2025.","DOI":"10.1038\/s41418-025-01462-2"},{"key":"8263_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02198-2","volume":"24","author":"MA Freitas-Cortez","year":"2025","unstructured":"Freitas-Cortez MA, Masrorpour F, Jiang H, Mahmud I, Lu Y, Huang A, et al. Cancer cells avoid ferroptosis induced by immune cells via fatty acid binding proteins. Molecular cancer. 2025;24:40.","journal-title":"Molecular cancer"},{"key":"8263_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103270","volume":"75","author":"K Zeng","year":"2024","unstructured":"Zeng K, Huang N, Liu N, Deng X, Mu Y, Zhang X, et al. LACTB suppresses liver cancer progression through regulation of ferroptosis. Redox Biol. 2024;75:103270.","journal-title":"Redox Biol"},{"key":"8263_CR18","first-page":"3826","volume":"22","author":"N Geng","year":"2018","unstructured":"Geng N, Shi BJ, Li SL, Zhong ZY, Li YC, Xua WL, et al. Knockdown of ferroportin accelerates erastin-induced ferroptosis in neuroblastoma cells. European Rev Med Pharmacol Sci. 2018;22:3826\u201336.","journal-title":"European Rev Med Pharmacol Sci"},{"key":"8263_CR19","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1038\/s41418-020-00685-9","volume":"28","author":"WD Bao","year":"2021","unstructured":"Bao WD, Pang P, Zhou XT, Hu F, Xiong W, Chen K, et al. Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer\u2019s disease. Cell death Differ. 2021;28:1548\u201362.","journal-title":"Cell death Differ"},{"key":"8263_CR20","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1073\/pnas.0908428107","volume":"107","author":"JP Morton","year":"2010","unstructured":"Morton JP, Timpson P, Karim SA, Ridgway RA, Athineos D, Doyle B, et al. Mutant p53 drives metastasis and overcomes growth arrest\/senescence in pancreatic cancer. Proceedings Natl Acad Sci USA. 2010;107:246\u201351.","journal-title":"Proceedings Natl Acad Sci USA"},{"key":"8263_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100884","volume":"4","author":"C Xue","year":"2023","unstructured":"Xue C, Chu Q, Zheng Q, Yuan X, Su Y, Bao Z, et al. Current understanding of the intratumoral microbiome in various tumors. Cell Rep. Med. 2023;4:100884.","journal-title":"Cell Rep. Med"},{"key":"8263_CR22","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S1470-2045(20)30148-0","volume":"21","author":"J Kleeff","year":"2020","unstructured":"Kleeff J, Michalski CW. Precision oncology for pancreatic cancer in real-world settings. Lancet Oncol. 2020;21:469\u201371.","journal-title":"Lancet Oncol"},{"key":"8263_CR23","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1021\/acs.chemrev.4c00546","volume":"125","author":"W Xu","year":"2025","unstructured":"Xu W, Guan G, Yue R, Dong Z, Lei L, Kang H, et al. Chemical Design of Magnetic Nanomaterials for Imaging and Ferroptosis-Based Cancer Therapy. Chemical Rev. 2025;125:1897\u2013961.","journal-title":"Chemical Rev"},{"key":"8263_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202412982","volume":"37","author":"C Qiao","year":"2025","unstructured":"Qiao C, Wang L, Huang C, Jia Q, Bao W, Guo P, et al. Engineered Bacteria Manipulate Cysteine Metabolism to Boost Ferroptosis-Based Pancreatic Ductal Adenocarcinoma Therapy. Advanced Mater (Deerfield Beach, Fla). 2025;37:e2412982.","journal-title":"Advanced Mater (Deerfield Beach, Fla)"},{"key":"8263_CR25","doi-asserted-by":"publisher","first-page":"4673","DOI":"10.1038\/s41388-022-02452-1","volume":"41","author":"E Boisteau","year":"2022","unstructured":"Boisteau E, Posseme C, Di Modugno F, Edeline J, Coulouarn C, Hrstka R, et al. Anterior gradient proteins in gastrointestinal cancers: from cell biology to pathophysiology. Oncogene. 2022;41:4673\u201385.","journal-title":"Oncogene"},{"key":"8263_CR26","first-page":"160","volume":"23","author":"ZB Qian","year":"2024","unstructured":"Qian ZB, Li JF, Xiong WY, Mao XR. Ferritinophagy: A new idea for liver diseases regulated by ferroptosis. Hepatobiliary & pancreatic diseases international. HBPD INT. 2024;23:160\u201370.","journal-title":"HBPD INT"},{"key":"8263_CR27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41392-024-02088-5","volume":"10","author":"F Alves","year":"2025","unstructured":"Alves F, Lane D, Nguyen TPM, Bush AI, Ayton S. In defence of ferroptosis. Signal Transduct Target Ther. 2025;10:2.","journal-title":"Signal Transduct Target Ther"},{"key":"8263_CR28","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41392-024-01969-z","volume":"9","author":"Q Ru","year":"2024","unstructured":"Ru Q, Li Y, Chen L, Wu Y, Min J, Wang F. Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects. Signal Transduct Target Ther. 2024;9:271.","journal-title":"Signal Transduct Target Ther"},{"key":"8263_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03329-x","volume":"24","author":"R Yu","year":"2024","unstructured":"Yu R, Hang Y, Tsai HI, Wang D, Zhu H. Iron metabolism: backfire of cancer cell stemness and therapeutic modalities. Cancer cell Int. 2024;24:157.","journal-title":"Cancer cell Int"},{"key":"8263_CR30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31:107\u201325.","journal-title":"Cell Res"},{"key":"8263_CR31","volume":"6","author":"H Meng","year":"2023","unstructured":"Meng H, Yu Y, Xie E, Wu Q, Yin X, Zhao B, et al. Hepatic HDAC3 Regulates Systemic Iron Homeostasis and Ferroptosis via the Hippo Signaling Pathway. Research (Wash, DC). 2023;6:0281.","journal-title":"Research (Wash, DC)"},{"key":"8263_CR32","doi-asserted-by":"crossref","unstructured":"Qu S, Jia W, Nie Y, Shi W, Chen C, Zhao Z, et al. AGR2: The Covert Driver and New Dawn of Hepatobiliary and Pancreatic Cancer Treatment. Biomolecules 2024;14.","DOI":"10.3390\/biom14070743"},{"key":"8263_CR33","unstructured":"Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer cell 2017;32:185\u2013203.e113."},{"key":"8263_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01517-8","volume":"9","author":"R Xu","year":"2023","unstructured":"Xu R, Wang W, Zhang W. Ferroptosis and the bidirectional regulatory factor p53. Cell death Discov. 2023;9:197.","journal-title":"Cell death Discov"},{"key":"8263_CR35","first-page":"847","volume":"118","author":"N Gattermann","year":"2021","unstructured":"Gattermann N, Muckenthaler MU, Kulozik AE, Metzgeroth G, Hastka J. The Evaluation of Iron Deficiency and Iron Overload. Deutsches Arzteblatt Int. 2021;118:847\u201356.","journal-title":"Deutsches Arzteblatt Int"},{"key":"8263_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/wsbm.1644","volume":"16","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Zou L, Li X, Guo L, Hu B, Ye H, et al. SLC40A1 in iron metabolism, ferroptosis, and disease: A review. WIREs mechanisms Dis. 2024;16:e1644.","journal-title":"WIREs mechanisms Dis"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08263-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08263-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08263-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T17:16:51Z","timestamp":1764609411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08263-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8263"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-08263-y","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"21 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Approval for the experiments was obtained from the Animal Ethics Committee of Southeast University (20200407060) by the ethical requirements. All procedures that involved human sample collection were approved by the tissue bank of The Ethics Committee of Zhongda Hospital (2024ZDSYLL517-Y01), Southeast University (Nanjing, China). Informed consent was obtained from human participants or their family members.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have reviewed and agreed to the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"877"}}